
Overview
Dr. Steven Hays, a pulmonologist, is medical director of the UCSF Lung Transplant Program, which is known for accepting patients with complex conditions while maintaining superior survival rates. His expertise is in caring for patients with end-stage lung disease who proceed through the lung transplant process. He treats conditions that include cystic fibrosis, emphysema associated with alpha-1 antitrypsin deficiency, and interstitial lung disease. In research, Hays focuses on studying how airway remodeling occurs in the transplanted lung. Hays earned his medical degree at the University of Kansas. He completed a residency in internal medicine at the University of Kansas Medical Center, where he served as chief resident, followed by a fellowship in pulmonary and critical care medicine at UCSF. He also completed a lung transplant fellowship at Stanford Health Care.
Dr. Hays is highly rated in 15 conditions, according to our data. His top areas of expertise are Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis, and Lung Transplant.
His clinical research consists of co-authoring 90 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
Accepted plan types not found. Please verify directly with the provider.
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Parnassus Ave., Sixth Floor, Room A6114, San Francisco, CA 94143
400 Parnassus Ave., Sixth Floor, San Francisco, CA 94143
400 Parnassus Ave., Sixth Floor, Room A6114, San Francisco, CA 94143
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Liver Disease And Liver Transplant
Dr. Jennifer C. Lai is a general and transplant hepatologist who specializes in caring for patients with chronic viral hepatitis, autoimmune disorders or cirrhosis, particularly those awaiting liver transplantation. Lai is active in patient-oriented research in three major areas: integrating core geriatric issues – such as frailty, disability, need for palliative care and multimorbidity (having more than one disease) – to patients with cirrhosis, investigating disparities in organ allocation and distribution, and assessing the impact of liver donor quality on outcomes. As principal investigator for the Functional Assessment in Liver Transplantation (FrAILT) Study funded by the National Institutes of Health, Lai applies measures of frailty and functional status to patients with end-stage liver disease awaiting transplantation. Her research lays the groundwork for preparing these patients with therapeutic interventions that may improve their outcomes and quality of life. She is director of hepatology research at UCSF. Lai earned her undergraduate degree from Stanford University and combined medical and master of business administration degrees from Tufts University. She completed her residency at New York–Presbyterian Hospital and fellowships in gastroenterology and transplant hepatology at UCSF. Lai is a member of the American Association for the Study of Liver Diseases, American Society of Transplantation, American Gastroenterological Association and American College of Gastroenterology. She is a fellow of the American College of Physicians. Dr. Lai is highly rated in 23 conditions, according to our data. Her top areas of expertise are Liver Failure, Ascites, Cirrhosis, Liver Transplant, and Kidney Transplant.
Office
Aijaz Ahmed is a Transplant Surgeon in Palo Alto, California. Dr. Ahmed is highly rated in 32 conditions, according to our data. His top areas of expertise are Hepatitis, Hepatitis C, Non-Alcoholic Fatty Liver Disease, Liver Transplant, and Hepatectomy.
Interstitial Lung Disease (ILD) Program
Dr. Paul J. Wolters specializes in the diagnosis and care of patients with interstitial lung disease, a category of disorders in which scarring of lung tissue affects breathing. Wolters is actively involved in research that aims to better understand the development of idiopathic pulmonary fibrosis, a type of interstitial lung disease. He is director of biological research for the UCSF Interstitial Lung Disease Program. Wolters received his medical degree from the University of Minnesota. He completed a residency in internal medicine at the University of Colorado, and a fellowship in pulmonary and critical care medicine at UCSF. He joined UCSF's division of pulmonary and critical care medicine in 1999. Dr. Wolters is highly rated in 12 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant.
Frequently Asked Questions about Dr. Steven Hays
How do I make an appointment with Dr. Steven Hays?
You can book an appointment with Dr. Steven Hays by calling their office at 415-353-2577. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Steven Hays a top-rated expert for Lung Transplant?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven Hays is classified as an Elite expert for Lung Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Steven Hays specialize in?
While Dr. Steven Hays is a Transplant Surgery, they have specific expertise in Lung Transplant, Hypersensitivity Pneumonitis, and Acute Interstitial Pneumonia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.
Does Dr. Steven Hays participate in research or clinical trials?
Yes. Dr. Steven Hays has published 90 articles and abstracts on conditions like Lung Transplant. You can view a list of Dr. Steven Hays's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Steven Hays accept my insurance?
Dr. Steven Hays accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-353-2577 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung TransplantDr. Hays isElite. Learn about Lung Transplant.
- Distinguished
- Acute Interstitial PneumoniaDr. Hays isDistinguished. Learn about Acute Interstitial Pneumonia.
- Alpha-1 Antitrypsin Deficiency (AATD)Dr. Hays isDistinguished. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- Cholesterol PneumoniaDr. Hays isDistinguished. Learn about Cholesterol Pneumonia.
- Cystic FibrosisDr. Hays isDistinguished. Learn about Cystic Fibrosis.
- Hypersensitivity PneumonitisDr. Hays isDistinguished. Learn about Hypersensitivity Pneumonitis.
- Idiopathic Pulmonary FibrosisDr. Hays isDistinguished. Learn about Idiopathic Pulmonary Fibrosis.
- Advanced
- Bronchiolitis ObliteransDr. Hays isAdvanced. Learn about Bronchiolitis Obliterans.
- BronchitisDr. Hays isAdvanced. Learn about Bronchitis.
- EmphysemaDr. Hays isAdvanced. Learn about Emphysema.
- PneumoniaDr. Hays isAdvanced. Learn about Pneumonia.
- Experienced
- AspergillosisDr. Hays isExperienced. Learn about Aspergillosis.
- Bronchogenic CystDr. Hays isExperienced. Learn about Bronchogenic Cyst.
- BullaeDr. Hays isExperienced. Learn about Bullae.
- Cerebral HypoxiaDr. Hays isExperienced. Learn about Cerebral Hypoxia.
- Chronic Obstructive Pulmonary Disease (COPD)
- Ciliary Dyskinesia-BronchiectasisDr. Hays isExperienced. Learn about Ciliary Dyskinesia-Bronchiectasis.


